
Capabilities
Technology
Last Updated
Since releasing their first cancer test to the market in 2012, Foundation Medicine has partnered with unosquare to transform cancer care with 5 different cancer tests and millions of reports delivered to physicians and patients.
Foundation Medicine produces in depth reporting on genomic mutations and recommended therapies individual to each patient.
unosquare has provided development support in every technical aspect from laboratory tools to customer billing platforms.
As Foundation Medicine outgrew their technology core, unosquare oversaw migration from Medicla Reporting to MR2, using a nodeJS/Oracle stack and later migrated to Postgres.
unosquare has been involved in the development and launch of 3 groundbreaking genomic cancer profiling products including Foundation One Heme, Liquid Biopsy Assay and FoundationOne Liquid. Our team has developed the UI that interprets genomic case information, managed migration to cloud-based technology, and set up and maintained back end engines behind it all.
Average Time to Fill 14 days | Duration 12 years |
Expert insights straight to your inbox
Subscribe for fresh ideas, case studies, tips, and trends to help you modernize your tech, build great teams, and create AI strategies that drive growth.
Help us customize your content with the following 2 questions:
Thank you!
We’re excited to have you with us! Keep an eye out for our next update – we can’t wait to share more.